- ►diabetesjournals.org N Kato, K Nemoto, K Nakanishi, R Morishita, Y Kaneda, … - Diabetes, 2005 - Am Diabetes Assoc Peripheral neuropathy is common and ultimately accounts for significant morbidity in
diabetes. Recently, several neurotrophic factors have been used to prevent progression of diabetic
neuropathy. In this study, we gave repeated intramuscular injections of the human ... Cited by 17 - Related articles - All 5 versions
PF Pradat, P Kennel, S Naimi-Sadaoui, F Finiels, … - Human gene …, 2001 - liebertonline.com Page 1. HUMAN GENE THERAPY 12:2237–2249 (December 10, 2001) Mary Ann Liebert,
Inc. Continuous Delivery of Neurotrophin 3 by Gene Therapy Has a Neuroprotective Effect
in Experimental Models of Diabetic and Acrylamide Neuropathies ... Cited by 33 - Related articles - BL Direct - All 4 versions
- ►diabetesjournals.org M Nakae, H Kamiya, K Naruse, N Horio, Y Ito, R … - Diabetes, 2006 - Am Diabetes Assoc Basic fibroblast growth factor (bFGF) stimulates angiogenesis and induces neural cell
regeneration. We investigated the effects of bFGF on diabetic neuropathy in streptozotocin-induced
diabetic rats. Diabetic rats were treated with human recombinant bFGF as follows: 1) ... Cited by 13 - Related articles - BL Direct - All 6 versions
- ►diabetesjournals.org JR Goss, WF Goins, D Lacomis, M Mata, JC Glorioso, … - Diabetes, 2002 - Am Diabetes Assoc Peripheral neuropathy is a common and debilitating complication of diabetes. In animal
models, neurotrophic factors can prevent progression of the neuropathy, but adverse effects
prevent systemic administration in adequate doses to treat human disease. We examined ... Cited by 80 - Related articles - BL Direct - All 6 versions
[CITATION] Diffuse glomerulosclerosis without tubular injury does not manifest renal …
